Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Scott G. Weiner$suffix/text()$suffix/text(), Olesya Baker$suffix/text()$suffix/text(), Dana Bernson$suffix/text()$suffix/text() & Jeremiah D. Schuur$suffix/text()$suffix/text(). (2022) One year mortality of patients treated with naloxone for opioid overdose by emergency medical services. Substance Abuse 43:1, pages 99-103.
Read now
Read now
Olufemi Ajumobi, Silvia R. Verdugo, Brian Labus, Patrick Reuther, Bradford Lee, Brandon Koch, Peter J. Davidson & Karla D. Wagner. (2022) Identification of Non-Fatal Opioid Overdose Cases Using 9-1-1 Computer Assisted Dispatch and Prehospital Patient Clinical Record Variables. Prehospital Emergency Care 26:6, pages 818-828.
Read now
Read now
Ola Dale. (2022) Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 203-217.
Read now
Read now
Scott A. Goldberg, Daniel A. Dworkis, Vincent T. Liao, Andrew J. Eyre, Jack Albert, Meghan M. Fawcett, Conor M. Narovec, James DiClemente & Scott G. Weiner. (2018) Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose. Prehospital Emergency Care 22:6, pages 788-794.
Read now
Read now
Jeremiah M. Kinsman & Kathy Robinson. (2018) National Systematic Legal Review of State Policies on Emergency Medical Services Licensure Levels' Authority to Administer Opioid Antagonists. Prehospital Emergency Care 22:5, pages 650-654.
Read now
Read now
Joseph M. Grover, Taibah Alabdrabalnabi, Mehul D. Patel, Michael W. Bachman, Timothy F. Platts-Mills, Jose G. Cabanas & Jefferson G. Williams. (2018) Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System. Prehospital Emergency Care 22:3, pages 281-289.
Read now
Read now
Nazey Gulec, Joseph Lahey, James C. Suozzi, Matthew Sholl, Charles D. MacLean & Daniel L. Wolfson. (2018) Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England. Prehospital Emergency Care 22:2, pages 163-169.
Read now
Read now
Michael J. Lynch, Joe Suyama & Francis X. Guyette. (2018) Scene Safety and Force Protection in the Era of Ultra-Potent Opioids. Prehospital Emergency Care 22:2, pages 157-162.
Read now
Read now
Mark Faul, Peter Lurie, Jeremiah M. Kinsman, Michael W. Dailey, Charmaine Crabaugh & Scott M. Sasser. (2017) Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing. Prehospital Emergency Care 21:4, pages 411-419.
Read now
Read now
Articles from other publishers (13)
Jennifer Bolster, Richard Armour, Michelle O’Toole, Meghan Lysko & Alan M. Batt. (2023) The paramedic role in caring for people who use illicit and controlled drugs: A scoping review. Paramedicine 20:4, pages 117-127.
Crossref
Crossref
Arne Kristian Skulberg, Ida Tylleskär, Morten Valberg, Anne‐Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Tore Skålhegg, Jan Barstein, Sindre Mellesmo & Ola Dale. (2022) Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double‐dummy, randomised, controlled trial. Addiction 117:6, pages 1658-1667.
Crossref
Crossref
John Thompson, Jenna Salter, Peter Bui, Logan Herbert, David Mills, Deborah Wagner & Christine Brent. (2021) Safety, Efficacy, and Cost of 0.4-mg Versus 2-mg Intranasal Naloxone for Treatment of Prehospital Opioid Overdose. Annals of Pharmacotherapy 56:3, pages 285-289.
Crossref
Crossref
Joshua Mastenbrook, Daniel Emrick, Laura D Bauler, James Markman, Tyler Koedam & William Fales. (2021) Evaluation of Basic Life Support First Responder Naloxone Administration Protocol Adherence. Cureus.
Crossref
Crossref
G. Franklin EdwardsIIIIII, Cassandra Mierisch, Brock Mutcheson, Kimberly Horn & Sarah Henrickson Parker. (2020) A review of performance assessment tools for rescuer response in opioid overdose simulations and training programs. Preventive Medicine Reports 20, pages 101232.
Crossref
Crossref
Lauren M. Maloney, Timur Alptunaer, Gia Coleman, Suleiman Ismael, Peter J. McKenna, R. Trevor Marshall, Cristina Hernandez & Daryl W. Williams. (2020) Prehospital Naloxone and Emergency Department Adverse Events: A Dose-Dependent Relationship. The Journal of Emergency Medicine 59:6, pages 872-883.
Crossref
Crossref
G. Anthony Fidacaro, Prarthi Patel, Gerard Carroll, Holly Bartimus, Krystal Hunter & Rick Hong. (2020) Do Patients Require Emergency Department Interventions After Prehospital Naloxone?. Journal of Addiction Medicine 14:3, pages 224-230.
Crossref
Crossref
Nancy Glober, Gene Hern, Owen McBride & Mary Mercer. (2020) Variations in the California Emergency Medical Services Response to Opioid Use Disorder. Western Journal of Emergency Medicine 21:3.
Crossref
Crossref
Justin Reinert, Rachel Leis, Alison Paplaskas & Deborah Bakle-Carn. (2019) Defining the Correlation Between Heroin Overdose and Length of Hospital Admissions. Journal of Pharmacy Technology 35:6, pages 243-250.
Crossref
Crossref
John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter & Ola Dale. (2019) Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 79:13, pages 1395-1418.
Crossref
Crossref
Kenneth Nugent, Patrick Matthews, Jamie Gissendaner, Mia Papas, Deborah Occident, Avkash Patel, Michelle Johnson, Ross E. Megargel & Jason T. Nomura. (2019) A Comparison of Efficacy of Treatment and Time to Administration of Naloxone by BLS and ALS Providers. Prehospital and Disaster Medicine 34:04, pages 350-355.
Crossref
Crossref
Arne Kristian Skulberg, Anders Åsberg, Hasse Zare Khiabani, Hilde Røstad, Ida Tylleskar & Ola Dale. (2019) Pharmacokinetics of a novel, approved, 1.4‐mg intranasal naloxone formulation for reversal of opioid overdose—a randomized controlled trial. Addiction 114:5, pages 859-867.
Crossref
Crossref
Gang Zhang, Myles R. McCrary & Ling Wei. 2019. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders
135
147
.